New insights into TGF-β–Smad signalling
暂无分享,去创建一个
[1] Hiroyuki Aburatani,et al. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells. , 2003, Cancer research.
[2] J. Massagué,et al. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.
[3] D. Riddle,et al. A Caenorhabditis elegans type I TGF beta receptor can function in the absence of type II kinase to promote larval development. , 2000, Development.
[4] K. Miyazono,et al. Two major Smad pathways in TGF‐β superfamily signalling , 2002, Genes to cells : devoted to molecular & cellular mechanisms.
[5] J. Massagué,et al. Structural basis of Smad2 recognition by the Smad anchor for receptor activation. , 2000, Science.
[6] Ulf Hellman,et al. Control of Smad7 stability by competition between acetylation and ubiquitination. , 2002, Molecular cell.
[7] J. Wrana,et al. TGF-β induces assembly of a Smad2–Smurf2 ubiquitin ligase complex that targets SnoN for degradation , 2001, Nature Cell Biology.
[8] C. Mummery,et al. Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis. , 2003, Cardiovascular research.
[9] J. Massagué,et al. A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. , 2003, Molecular cell.
[10] R. Weinberg,et al. Cooperative Binding of Transforming Growth Factor (TGF)-β2 to the Types I and II TGF-β Receptors (*) , 1995, The Journal of Biological Chemistry.
[11] H. Lodish,et al. Importin β Mediates Nuclear Translocation of Smad 3* , 2000, The Journal of Biological Chemistry.
[12] Kohei Miyazono,et al. Ligand Binding and Functional Properties of Betaglycan, a Co-receptor of the Transforming Growth Factor-β Superfamily , 2001, The Journal of Biological Chemistry.
[13] M. Uhler,et al. A Transforming Growth Factor β-Induced Smad3/Smad4 Complex Directly Activates Protein Kinase A , 2004, Molecular and Cellular Biology.
[14] C. Hill,et al. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. , 2002, Molecular cell.
[15] H. Lodish,et al. A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[16] Liliana Attisano,et al. SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor , 1998, Cell.
[17] E. Nishida,et al. Regulation of intracellular dynamics of Smad4 by its leucine‐rich nuclear export signal , 2000, EMBO reports.
[18] Teresa Reguly,et al. In or out? The dynamics of Smad nucleocytoplasmic shuttling. , 2003, Trends in cell biology.
[19] T. Muir,et al. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. , 2001, Molecular cell.
[20] A. Philip,et al. Glycosylphosphatidylinositol-anchored Proteins Regulate Transforming Growth Factor-β Signaling in Human Keratinocytes* , 2003, Journal of Biological Chemistry.
[21] J. Massagué,et al. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus. , 2002, Molecular cell.
[22] S. Dupont,et al. Links between Tumor Suppressors p53 Is Required for TGF-β Gene Responses by Cooperating with Smads , 2003, Cell.
[23] Steven Dyson,et al. The Interpretation of Position in a Morphogen Gradient as Revealed by Occupancy of Activin Receptors , 1998, Cell.
[24] J. Desgrosellier,et al. Transforming growth factor beta (TGFbeta ) signaling via differential activation of activin receptor-like kinases 2 and 5 during cardiac development. Role in regulating parasympathetic responsiveness. , 2002, The Journal of biological chemistry.
[25] Jonas Larsson,et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. , 2003, Molecular cell.
[26] Xu Cao,et al. GADD34–PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor , 2004, The Journal of cell biology.
[27] Jeffrey L. Wrana,et al. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation , 1999, Nature.
[28] C. Hill,et al. Transforming Growth Factor β-Independent Shuttling of Smad4 between the Cytoplasm and Nucleus , 2000, Molecular and Cellular Biology.
[29] A. Suzuki,et al. Concentration-dependent patterning of the Xenopus ectoderm by BMP4 and its signal transducer Smad1. , 1997, Development.
[30] R. Weinberg,et al. Heart and Liver Defects and Reduced Transforming Growth Factor β2 Sensitivity in Transforming Growth Factor β Type III Receptor-Deficient Embryos , 2003, Molecular and Cellular Biology.
[31] K. Miyazono,et al. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta. , 1994, The Journal of biological chemistry.
[32] Jeffrey L. Wrana,et al. Signal Transduction by the TGF-β Superfamily , 2002, Science.
[33] X. Yang,et al. Regulation of large-scale chromatin unfolding by Smad4. , 2004, Biochemical and biophysical research communications.
[34] M. Whitman. Nodal signaling in early vertebrate embryos: themes and variations. , 2001, Developmental cell.
[35] F. Melchior,et al. Activation of Transforming Growth Factor-β Signaling by SUMO-1 Modification of Tumor Suppressor Smad4/DPC4* , 2003, Journal of Biological Chemistry.
[36] P. Bates,et al. Recognition of Phosphorylated-Smad2-Containing Complexes by a Novel Smad Interaction Motif , 2004, Molecular and Cellular Biology.
[37] Morgan Huse,et al. Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12 , 1999, Cell.
[38] Jing Qing,et al. Transforming Growth Factor (cid:2) /Smad3 Signaling Regulates IRF-7 Function and Transcriptional Activation of the Beta Interferon Promoter , 2022 .
[39] H. Lodish,et al. Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.
[40] Claudio Alarcón,et al. Distinct Domain Utilization by Smad3 and Smad4 for Nucleoporin Interaction and Nuclear Import* , 2003, Journal of Biological Chemistry.
[41] H. Lodish,et al. Oligomeric Structure of Type I and Type II Transforming Growth Factor β Receptors: Homodimers Form in the ER and Persist at the Plasma Membrane , 1998, The Journal of cell biology.
[42] Yigong Shi,et al. Crystal Structure of a Smad MH1 Domain Bound to DNA Insights on DNA Binding in TGF-β Signaling , 1998, Cell.
[43] L. Attisano,et al. Role of Endoglin in Cellular Responses to Transforming Growth Factor-β , 1998, The Journal of Biological Chemistry.
[44] Xin-Hua Feng,et al. Smad6 Recruits Transcription Corepressor CtBP To Repress Bone Morphogenetic Protein-Induced Transcription , 2003, Molecular and Cellular Biology.
[45] J. Massagué,et al. The nuclear import function of Smad2 is masked by SARA and unmasked by TGFb-dependent phosphorylation , 2000, Nature Cell Biology.
[46] Takeshi Imamura,et al. Arkadia amplifies TGF‐β superfamily signalling through degradation of Smad7 , 2003 .
[47] M. Reiss,et al. TLP, a novel modulator of TGF‐β signaling, has opposite effects on Smad2‐ and Smad3‐dependent signaling , 2003, The EMBO journal.
[48] P. Hoodless,et al. Targeted Disruption in Murine Cells Reveals Variable Requirement for Smad4 in Transforming Growth Factor β-related Signaling* , 2000, The Journal of Biological Chemistry.
[49] C. Heldin,et al. Transforming growth factor-beta induces nuclear import of Smad3 in an importin-beta1 and Ran-dependent manner. , 2001, Molecular biology of the cell.
[50] J. Massagué,et al. Complementation between kinase‐defective and activation‐defective TGF‐beta receptors reveals a novel form of receptor cooperativity essential for signaling. , 1996, The EMBO journal.
[51] P. Bates,et al. Different Smad2 partners bind a common hydrophobic pocket in Smad2 via a defined proline‐rich motif , 2002, The EMBO journal.
[52] C. Heldin,et al. Smad regulation in TGF-beta signal transduction. , 2001, Journal of cell science.
[53] Xin Chen,et al. A transcriptional partner for MAD proteins in TGF-β signalling , 1996, Nature.
[54] Harvey F Lodish,et al. An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity , 2003, Oncogene.
[55] Xiao-Fan Wang,et al. ß-Arrestin 2 Mediates Endocytosis of Type III TGF-ß Receptor and Down-Regulation of Its Signaling , 2003, Science.
[56] C. Hill,et al. Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrest , 2003, Oncogene.
[57] P. Donahoe,et al. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[58] Minoru Watanabe,et al. Smad4 and FAST-1 in the assembly of activin-responsive factor , 1997, Nature.
[59] M. Pisano,et al. Identification of three novel Smad binding proteins involved in cell polarity , 2003, FEBS letters.
[60] S. Germain,et al. Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. , 2000, Genes & development.
[61] H. Lodish,et al. Signaling by chimeric erythropoietin‐TGF‐beta receptors: homodimerization of the cytoplasmic domain of the type I TGF‐beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction. , 1996, The EMBO journal.
[62] H. Lodish,et al. Positive and negative regulation of type II TGF‐β receptor signal transduction by autophosphorylation on multiple serine residues , 1997, The EMBO journal.
[63] K. Luo,et al. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosis , 2004, Nature Cell Biology.
[64] Fang Liu,et al. Repression of Smad4 transcriptional activity by SUMO modification. , 2004, The Biochemical journal.
[65] Ying E. Zhang,et al. Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.
[66] C. Klein,et al. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. , 2004, Molecular endocrinology.
[67] C. Mummery,et al. Expression of ALK‐1, a type 1 serine/threonine kinase receptor, coincides with sites of vasculogenesis and angiogenesis in early mouse development , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.
[68] Jeffrey L. Wrana,et al. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover , 2003, Nature Cell Biology.
[69] J. Wrana,et al. Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis , 2003, Molecular and Cellular Biology.